Drug Repurposing Market Size, Share & Trends Report

Drug Repurposing Market (2025 - 2033) Size, Share & Trends Analysis Report By Disease Area (Oncology, Neurology Disorders, Infectious Diseases, Cardiovascular Conditions, Metabolic Disorders), By Drug Type, By End Use, By Region, And Segment Forecasts

Market Segmentation

Drug Repurposing Disease Outlook (Revenue, USD Million, 2021 - 2033)
- Oncology
- Neurology Disorders
- Infectious Diseases
- Cardiovascular Conditions
- Metabolic Disorders
- Others Therapeutic Areas
Drug Repurposing Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
- Conventional Small Molecules
- Biologics and Peptide-based Drugs
Drug Repurposing End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceutical & Pharmaceutical Companies
- Clinical Research Organizations (CROs)
- Universities & Research Institutions
Drug Repurposing Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Drug Repurposing Market, by Disease Area
    - Oncology
    - Neurology Disorders
    - Infectious Diseases
    - Cardiovascular Conditions
    - Metabolic Disorders
    - Others Therapeutic Areas
  - North America Drug Repurposing Market, by Drug Type
    - Conventional Small Molecules
    - Biologics and Peptide-based Drugs
  - North America Drug Repurposing Market, by End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - Clinical Research Organizations (CROs)
    - Universities & Research Institutions
  - U.S.
    - U.S. Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - U.S. Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - U.S. Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Canada
    - Canada Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Canada Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Canada Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Mexico
    - Mexico Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Mexico Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Mexico Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
- Europe
  - Europe Drug Repurposing Market, by Disease Area
    - Oncology
    - Neurology Disorders
    - Infectious Diseases
    - Cardiovascular Conditions
    - Metabolic Disorders
    - Others Therapeutic Areas
  - Europe Drug Repurposing Market, by Drug Type
    - Conventional Small Molecules
    - Biologics and Peptide-based Drugs
  - Europe Drug Repurposing Market, by End Use
    - Biopharmaceutical & Pharmaceutical Companies
    - Clinical Research Organizations (CROs)
    - Universities & Research Institutions
  - UK
    - UK Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - UK Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - UK Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Germany
    - Germany Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Germany Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Germany Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - France
    - France Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - France Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - France Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Italy
    - Italy Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Italy Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Italy Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Spain
    - Spain Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Spain Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Spain Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Denmark
    - Denmark Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Denmark Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Denmark Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Sweden
    - Sweden Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Sweden Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Sweden Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Norway
    - Norway Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Norway Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Norway Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
  - Asia Pacific
    - Asia Pacific Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Asia Pacific Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Asia Pacific Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
    - Japan
      - Japan Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Japan Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Japan Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - China
      - China Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - China Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - China Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - India
      - India Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - India Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - India Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - Australia
      - Australia Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Australia Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Australia Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - South Korea
      - South Korea Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - South Korea Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - South Korea Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - Thailand
      - Thailand Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Thailand Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Thailand Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
  - Latin America
    - Latin America Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Latin America Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Latin America Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
    - Brazil
      - Brazil Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Brazil Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Brazil Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - Argentina
      - Argentina Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Argentina Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Argentina Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
  - Middle East & Africa
    - Middle East & Africa Drug Repurposing Market, by Disease Area
      - Oncology
      - Neurology Disorders
      - Infectious Diseases
      - Cardiovascular Conditions
      - Metabolic Disorders
      - Others Therapeutic Areas
    - Middle East & Africa Drug Repurposing Market, by Drug Type
      - Conventional Small Molecules
      - Biologics and Peptide-based Drugs
    - Middle East & Africa Drug Repurposing Market, by End Use
      - Biopharmaceutical & Pharmaceutical Companies
      - Clinical Research Organizations (CROs)
      - Universities & Research Institutions
    - South Africa
      - South Africa Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - South Africa Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - South Africa Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - Saudi Arabia
      - Saudi Arabia Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Saudi Arabia Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Saudi Arabia Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - UAE
      - UAE Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - UAE Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - UAE Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions
    - Kuwait
      - Kuwait Drug Repurposing Market, by Disease Area
        
        Oncology
        
        Neurology Disorders
        
        Infectious Diseases
        
        Cardiovascular Conditions
        
        Metabolic Disorders
        
        Others Therapeutic Areas
      - Kuwait Drug Repurposing Market, by Drug Type
        
        Conventional Small Molecules
        
        Biologics and Peptide-based Drugs
      - Kuwait Drug Repurposing Market, by End Use
        
        Biopharmaceutical & Pharmaceutical Companies
        
        Clinical Research Organizations (CROs)
        
        Universities & Research Institutions

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments